Skip to main content

Master of Public Health

Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.

AUTHORS

Roumie CL , Min JY , Greevy RA , Grijalva CG , Hung AM , Liu X , Elasy T , Griffin MR , . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2016 1 25; ().
  • NIHMSID: 9711805

ABSTRACT

Hypoglycemia remains a common life-threatening event associated with diabetes treatment. We compared the risk of first or recurrent hypoglycemia event among metformin initiators who intensified treatment with insulin versus sulfonylurea.

Hypoglycemia remains a common life-threatening event associated with diabetes treatment. We compared the risk of first or recurrent hypoglycemia event among metformin initiators who intensified treatment with insulin versus sulfonylurea.

Tags: